Abstract

Lung cancer is the second most common cancer in both men and women. The American Cancer Society's estimates about 228,820 new cases of lung cancer and about 135,720 deaths from lung cancer in 2020. The clinical outcome of the lung cancer patients has markedly improved since the advent of molecular diagnostic tests having the evidence of clinical utility.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.